FARE Sends Letter to FDA Regarding Draft Guidance on Voluntary Sesame Labeling
A Statement from Lisa Gable, Chief Executive Officer, FARE (Food Allergy Research & Education): “On behalf of the 32 million Americans who suffer from life-threatening food allergies, and the 1.5 million Americans allergic to sesame, FARE is disappointed in the FDA’s proposed guidance to industry regarding the ‘Voluntary Disclosure of Sesame as an Allergen’ issued on November 10. While the guidance is a step in the right direction, sesame needs to be recognized as the ninth top allergen and it must be labeled.”
Media Contact:
About FARE (Food Allergy Research & Education)
FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across their journey of managing the disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, treatment and a cure, while building awareness and community. To learn more, visit FoodAllergy.org.